About the Company
We do not have any company description for PhaseBio Pharmaceuticals Inc at the moment.
Please visit https://phasebio.com/ for more information about the company.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PHAS News
PhaseBio Pharmaceuticals, Inc. (PHASQ)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Ravi Viswanathan's Net Worth
Ravi Viswanathan has an estimated net worth of $364 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., Cascadian Therapeutics, Inc ...
NEA Partners 13, Limited Partnership's Net Worth
Who is NEA Partners 13, Limited Partnership? NEA Partners 13, Limited Partnership has an estimated net worth of $1.67 Billion. This is based on reported shares across multiple companies, which ...
ABOS Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer’s disease. The company focuses on advancing a targeted ...
EyePoint Pharmaceuticals, Inc. (EYPT)
- Charles Wykoff, M.D., Ph.D. joins Carl Regillo, M.D., FACS as co-chair of Scientific Advisory Board – - Usha Chakravarthy, M.B.B.S, PhD., Allen Ho, M.D. FACS ...
Actinium Pharmaceuticals Inc ATNM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the development of therapeutics to treat patients with neurological disorders in Canada. Its clinical ...
ANI Pharmaceuticals Inc ANIP
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
PhaseBio Pharmaceuticals Inc.
Shark Tank's Kevin O’Leary is serious about buying TikTok. He shares his full plan to buy the embattled app and the changes he would implement on his first day.
PhaseBio Pharmaceuticals Inc. (PHASQ)
We’re sorry, we are currently experiencing some issues, please try again later. Our team is working diligently to resolve the issue. Thank you for your patience and ...
PhaseBio Pharmaceuticals, Inc. (PHASQ)
*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Loading the latest forecasts...